Clinical Trials
3 trialsNCT03455556 2023-01-06
Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer
Mayo Clinic
Phase 1 Terminated
NCT03102320 2022-06-30
ARCS-Multi
Bayer
Phase 1 Completed
NCT02639091 2019-11-07
Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
Bayer
Phase 1 Completed